ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

Satcher Nominated For Surgeon General, Asst. Sec. for Health.

September 19, 1997

RFA On Breast Tumor Factors Patients Survival

June 20, 1980

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

Three Venerable Acronyms Fade Away As Cooperative Groups Form “Alliance”

June 17, 2011

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975